Cardiac Biomarkers (Diagnostics of Ischemic Heart Disease) Part 1
Born to Age: When Adult Congenital Heart Disease Converges With Geroscience | JACC: Advances
Which Marker is the Best for Assessing Acute Heart Failure or Does it Matter? - American College of Cardiology
Biomarkers in Routine Heart Failure Clinical Care
Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools - Marcovina - 2007 - Journal of Internal Medicine - Wiley Online Library
Cardiac Enzymes / Cardiac Biomarkers Topic Review | Learn the Heart
Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases | Metabolic Syndrome and Related Disorders
Established and Emerging Roles of Biomarkers in Heart Failure | Circulation Research
Integrated diagnostic approach in coronary heart disease. The figure... | Download Scientific Diagram
Cardiovascular Risk: What Should We Measure?
Congestive heart failure: Symptoms, treatment, and more
Screening for Cardiovascular Disease Risk with Electrocardiography: Recommendation Statement | AAFP
Which Marker is the Best for Assessing Acute Heart Failure or Does it Matter? - American College of Cardiology
Biomarkers in Routine Heart Failure Clinical Care
Markers of Inflammation and Cardiovascular Disease | Circulation
Markers of Inflammation and Cardiovascular Disease | Circulation
The Evolution and Direction of the Cardiac Biomarker | EMJ Reviews
Biomarkers in Heart Failure | NEJM
Cardiovascular Disease Concerns Pump Sales of Cardiac Markers to $2.5 Billion | DAIC
Inflammation and resolution signaling in cardiac repair and heart failure - eBioMedicine
Cardiac Markers: Definition and Efficacy, Markers of Myocardial Necrosis and Ischemia, Acute Coronary Syndrome Testing Strategy
The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions - eBioMedicine
Biomarkers in Cardiovascular Medicine | Revista Española de Cardiología
The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
Which Marker is the Best for Assessing Acute Heart Failure or Does it Matter? - American College of Cardiology
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure | Nature Communications
